Literature DB >> 6830452

A comparison of clinical features in early- and late-onset primary degenerative dementia. One entity or two?

B Seltzer, I Sherwin.   

Abstract

The prevalence of a number of clinical features occurring in patients with early- (before age 65) and late-onset primary degenerative dementia of the Alzheimer type (PDDAT) are compared. The data from a total of 65 patients demonstrated a greater prevalence of language disturbance, a disproportionate number of left-handers, and a much shorter relative survival time in the early-onset group. Taken together with other data, these findings indicate a degree of heterogeneity in the clinical features of patients with PDDAT and suggest a possible heightened selective vulnerability of the left hemisphere in early-onset cases. We interpret the data as raising the possibility that the current view of PDDAT as a unitary disorder may not be entirely valid.

Entities:  

Mesh:

Year:  1983        PMID: 6830452     DOI: 10.1001/archneur.1983.04050030037006

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  41 in total

Review 1.  Alzheimer's disease.

Authors:  M Rossor
Journal:  Postgrad Med J       Date:  1992-07       Impact factor: 2.401

2.  Heterogeneity in Alzheimer's disease: progression rate segregated by distinct neuropsychological and cerebral metabolic profiles.

Authors:  U M Mann; E Mohr; M Gearing; T N Chase
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

3.  Working memory and FDG-PET dissociate early and late onset Alzheimer disease patients.

Authors:  Grégoria Kalpouzos; Francis Eustache; Vincent de la Sayette; Fausto Viader; Gaël Chételat; Béatrice Desgranges
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

4.  Functional connectivity changes differ in early and late-onset Alzheimer's disease.

Authors:  Natalina Gour; Olivier Felician; Mira Didic; Lejla Koric; Claude Gueriot; Valérie Chanoine; Sylviane Confort-Gouny; Maxime Guye; Mathieu Ceccaldi; Jean Philippe Ranjeva
Journal:  Hum Brain Mapp       Date:  2013-10-05       Impact factor: 5.038

5.  Seizures in Alzheimer disease: who, when, and how common?

Authors:  Nikolaos Scarmeas; Lawrence S Honig; Hyunmi Choi; Julio Cantero; Jason Brandt; Deborah Blacker; Marilyn Albert; Joan C Amatniek; Karen Marder; Karen Bell; W Allen Hauser; Yaakov Stern
Journal:  Arch Neurol       Date:  2009-08

Review 6.  Staging Alzheimer's disease progression with multimodality neuroimaging.

Authors:  Michael Ewers; Giovanni B Frisoni; Stefan J Teipel; Lea T Grinberg; Edson Amaro; Helmut Heinsen; Paul M Thompson; Harald Hampel
Journal:  Prog Neurobiol       Date:  2011-06-22       Impact factor: 11.685

7.  Differentiated clinical presentation of early and late-onset Alzheimer's disease: is 65 years of age providing a reliable threshold?

Authors:  Antonio Palasí; Belén Gutiérrez-Iglesias; Montse Alegret; Francesc Pujadas; Mikel Olabarrieta; Diana Liébana; Manolo Quintana; José Álvarez-Sabín; Mercè Boada
Journal:  J Neurol       Date:  2015-03-21       Impact factor: 4.849

8.  Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden.

Authors:  Gil D Rabinovici; Ansgar J Furst; Adi Alkalay; Caroline A Racine; James P O'Neil; Mustafa Janabi; Suzanne L Baker; Neha Agarwal; Stephen J Bonasera; Elizabeth C Mormino; Michael W Weiner; Maria L Gorno-Tempini; Howard J Rosen; Bruce L Miller; William J Jagust
Journal:  Brain       Date:  2010-01-15       Impact factor: 13.501

9.  Frontal Callosal Fiber Integrity Selectively Predicts Coordinated Psychomotor Performance in Chronic Alcoholism.

Authors:  Margaret J Rosenbloom; Stephanie A Sassoon; Rosemary Fama; Edith V Sullivan; Adolf Pfefferbaum
Journal:  Brain Imaging Behav       Date:  2008       Impact factor: 3.978

10.  A comparison of changes in the nucleus basalis and locus caeruleus in Alzheimer's disease.

Authors:  D M Mann; P O Yates; B Marcyniuk
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-02       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.